Drawing for 360 HCP

USPTO serial 79149276

360 HCP

Reviewed by CopyMark Law Group

Reg. 4693878Status 706Registered
Filing date
Status date
Registration date
Mar 3, 2015
Examiner
WEIGLE, KATHERINE CONNOLLY
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with 360 HCP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Bruce S. Londa

Bruce S. Londa Norris McLaughlin P.A.7 Times Square21st FloorNew York, NY 10036-6524

Goods and services

ClassDescriptionStatusFirst use
001[ Chemicals and chemical preparations for industrial and scientific use; ] in-vitro diagnostic preparations used in science, in particular for industrial and scientific use; chemical test kits, consisting of immunological or marked antibodies and related reagents on serological and immunogenic basis and reagents therefor for quality control analysis of biological pharmaceutics for laboratory or research use; reagent kits comprised of reagents for scientific or research purposes for conducting the enzyme-linked immune adsorption test (ELISA) not for medical or veterinary purposes; [ chemical preparations for scientific purposes in form of buffers, salts, solvents and reactants for the afore-mentioned test kits; ] chemical reagents for non-medical purposes for buffer solutions used in assay kits; antibody solutions and conjugates and derivatives made from them, namely, biochemical for in vitro and in vivo scientific use; biochemical reagents for use in laboratories [ ; chemical, biochemical or biological preparations and chemical reagents and kits made thereof for the detection of cancer conditions, neoplastic conditions, inflammation conditions, infection conditions, degenerative conditions, genetically abnormal or morbid conditions, proliferative abnormal or morbid conditions, vascular diseases, premalignant conditions, malignant conditions, cancer and congenital defects, all for scientific and research purposes ]ACTIVE
009Laboratory equipment, namely, antibody-coated laboratory worktops and microtiter plates, in particular for specifying cell typeACTIVE
042[ Services of a biologist, chemistry or biochemistry services, namely, biochemical research and development, custom design and development of biochemical assays; services of a bacteriological, molecular-biological or chemical laboratory, namely, research and testing and scientific laboratory services; research, development and corresponding consultancy in the field of diagnostics, in particular product development of reagents and test kits, in particular on serological and immunogenic basis for the chemistry, biochemistry, bacteriology and biotechnology fields; conducting scientific testing and analysis in the field of virus diagnostics for determining contaminations in the production of active substances; development of testing methods and test kits for the chemistry, biochemistry, bacteriology and biotechnology fields; services in the field of technical and scientific supports, namely, scientific testing of immunoassays for determining contaminations of biological active substances and related diagnostic services in the field of research related thereto; biotechnological services, namely, research and development in the biotechnology field; consultancy relating to chemical and pharmaceutical research, consultancy relating to the development of diagnostic tests and procedures for the chemistry, biochemistry, bacteriology and biotechnology fields ]SECTION 71 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 23, 2026INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jun 23, 2025NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Jun 23, 202571AGREGISTERED-SEC.71 ACCEPTED
Jun 18, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 5, 2025ES71TEAS SECTION 71 RECEIVED
Mar 3, 2024REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Feb 1, 2024RNWLINTERNATIONAL REGISTRATION RENEWED
Jun 5, 2022INNPPARTIAL INVALIDATION PROCESSED BY THE IB
Apr 5, 2022INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Apr 4, 2022INPCINVALIDATION PROCESSED
Nov 17, 2021INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Mar 17, 2021NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Mar 17, 202171.PREGISTERED - PARTIAL SEC 71 ACCEPTED
Mar 16, 2021APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 12, 2021ES71TEAS SECTION 71 RECEIVED
Mar 3, 2020REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Feb 6, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 17, 2015FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Jun 30, 2015FICSFINAL DISPOSITION NOTICE SENT TO IB
Jun 30, 2015FIMPFINAL DISPOSITION PROCESSED
Jun 3, 2015FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 3, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 19, 2014GPNXNOTIFICATION PROCESSED BY IB
Dec 16, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 16, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 3, 2014OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 3, 2014OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 26, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 10, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 31, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Oct 30, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Oct 30, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 27, 2014ALIEASSIGNED TO LIE
Oct 22, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 22, 2014RFNTREFUSAL PROCESSED BY IB
Aug 1, 2014RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 1, 2014RFRRREFUSAL PROCESSED BY MPU
Aug 1, 2014MAFRAPPLICATION FILING RECEIPT MAILED
Jul 31, 2014RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 30, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 28, 2014DOCKASSIGNED TO EXAMINER
Jul 28, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 21, 2014REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance